Portfolio company
Strategic Partners
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops drug candidates for serious genetic disorders to serve patients with rare diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tay Therapeutics
This biotech company develops small molecule oral gene therapies for patients with rare genetic disorders and inflammatory conditions through licensing and strategic partnerships.
Stridebio
This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.
Code Bio
This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.
Solid Biosciences
This life science company develops gene therapy candidates for patients living with rare neuromuscular and cardiac diseases.
Scenic Biotech
This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.
LogicBio
This company develops gene editing and delivery platforms to provide one-time treatments for patients with serious, early-onset rare genetic diseases.
Rocket Pharma
This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.